Rocket


News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

GENMAB A/S (GMAB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Articles of Association"
09/28/2023 6-K Quarterly results
08/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Articles of Association"
08/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement"
08/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"15,500 - 16,500"
07/21/2023 6-K Quarterly results
07/20/2023 6-K Quarterly results
06/08/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated June 8, 2023: Grant of Restricted Stock Units and Warrants to Employees in Genmab"
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated June 1, 2023: Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons"
05/31/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated May 31, 2023: Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons"
05/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Articles of Association"
05/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated May 19, 2023: EPKINLY™ (epcoritamab-bysp) Approved by U.S. Food and Drug Administration as the First and Only Bispecific Antibody to Treat Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)"
05/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Interim Report",
"Interim Report"
04/24/2023 6-K Quarterly results
04/20/2023 6-K Quarterly results
04/18/2023 6-K Quarterly results
04/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated April 6, 2023: Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons"
04/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated April 3, 2023: Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons"
04/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement",
"Company Announcement"
04/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Articles of Association"
03/29/2023 6-K Quarterly results
03/29/2023 6-K Quarterly results
03/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement",
"Company Announcement"
03/20/2023 6-K Quarterly results
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated March 13, 2023: Transactions in connection with share buyback program- Mar 13 2023",
"Company Announcement Dated March 13, 2023: Transactions in connection with share buyback program- Mar 13 2023"
03/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated March 06, 2023: Transactions in connection with share buyback program- Mar 03 2023",
"Company Announcement Dated March 06, 2023: Transactions in connection with share buyback program- Mar 03 2023"
03/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Articles of Association"
02/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated February 28, 2023: Capital Increase in Genmab as a Result of Employee Warrant Exercise"
02/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Articles of Association"
02/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated February 27, 2023: Transactions in connection with share buy-back program",
"Company Announcement Dated February 27, 2023: Transactions in connection with share buy-back program"
02/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated February 24, 2023: Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab",
"Company Announcement Dated February 24, 2023: Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons"
02/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated February 23, 2023: Notice to Convene the Annual General Meeting of Genmab A/S"
02/22/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Company Announcement Dated February 22, 2023: Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons"
02/22/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy